King’s College London & the EU-AIMS project


I am a participant, representing Felser Ltd, all credit to King’s College London and EU-AIMS project. It is the largest research grant ever given for neurodevelopmental conditions awarded by the Innovative Medicines Initiative to an international consortium.

Professor Declan Murphy, the project academic lead and Director of the Sackler Institute for Translational Neurodevelopment at the IoPPN at King’s said:

“This grant will allow us to bridge the gap between basic biology and the clinic by offering personalised approaches that address problems which really impact autistic people’s lives.” 

This crucial for understanding what drives good outcomes for autistic people and their families. From the educational point of view, the best outcome is to be able to live independently, and to develop the higher level skills that lead to it. It is important that the gaps in early skills are addressed. We developed PAGS Profile Assessment and Goal Setting framework, which shows the strengths of the child as well as their developmental needs.